Cargando…

Mir-34: A New Weapon Against Cancer?

The microRNA(miRNA)-34a is a key regulator of tumor suppression. It controls the expression of a plethora of target proteins involved in cell cycle, differentiation and apoptosis, and antagonizes processes that are necessary for basic cancer cell viability as well as cancer stemness, metastasis, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Misso, Gabriella, Di Martino, Maria Teresa, De Rosa, Giuseppe, Farooqi, Ammad Ahmad, Lombardi, Angela, Campani, Virginia, Zarone, Mayra Rachele, Gullà, Annamaria, Tagliaferri, Pierosandro, Tassone, Pierfrancesco, Caraglia, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222652/
https://www.ncbi.nlm.nih.gov/pubmed/25247240
http://dx.doi.org/10.1038/mtna.2014.47
_version_ 1782343076010786816
author Misso, Gabriella
Di Martino, Maria Teresa
De Rosa, Giuseppe
Farooqi, Ammad Ahmad
Lombardi, Angela
Campani, Virginia
Zarone, Mayra Rachele
Gullà, Annamaria
Tagliaferri, Pierosandro
Tassone, Pierfrancesco
Caraglia, Michele
author_facet Misso, Gabriella
Di Martino, Maria Teresa
De Rosa, Giuseppe
Farooqi, Ammad Ahmad
Lombardi, Angela
Campani, Virginia
Zarone, Mayra Rachele
Gullà, Annamaria
Tagliaferri, Pierosandro
Tassone, Pierfrancesco
Caraglia, Michele
author_sort Misso, Gabriella
collection PubMed
description The microRNA(miRNA)-34a is a key regulator of tumor suppression. It controls the expression of a plethora of target proteins involved in cell cycle, differentiation and apoptosis, and antagonizes processes that are necessary for basic cancer cell viability as well as cancer stemness, metastasis, and chemoresistance. In this review, we focus on the molecular mechanisms of miR-34a-mediated tumor suppression, giving emphasis on the main miR-34a targets, as well as on the principal regulators involved in the modulation of this miRNA. Moreover, we shed light on the miR-34a role in modulating responsiveness to chemotherapy and on the phytonutrients-mediated regulation of miR-34a expression and activity in cancer cells. Given the broad anti-oncogenic activity of miR-34a, we also discuss the substantial benefits of a new therapeutic concept based on nanotechnology delivery of miRNA mimics. In fact, the replacement of oncosuppressor miRNAs provides an effective strategy against tumor heterogeneity and the selective RNA-based delivery systems seems to be an excellent platform for a safe and effective targeting of the tumor.
format Online
Article
Text
id pubmed-4222652
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-42226522014-11-13 Mir-34: A New Weapon Against Cancer? Misso, Gabriella Di Martino, Maria Teresa De Rosa, Giuseppe Farooqi, Ammad Ahmad Lombardi, Angela Campani, Virginia Zarone, Mayra Rachele Gullà, Annamaria Tagliaferri, Pierosandro Tassone, Pierfrancesco Caraglia, Michele Mol Ther Nucleic Acids Review The microRNA(miRNA)-34a is a key regulator of tumor suppression. It controls the expression of a plethora of target proteins involved in cell cycle, differentiation and apoptosis, and antagonizes processes that are necessary for basic cancer cell viability as well as cancer stemness, metastasis, and chemoresistance. In this review, we focus on the molecular mechanisms of miR-34a-mediated tumor suppression, giving emphasis on the main miR-34a targets, as well as on the principal regulators involved in the modulation of this miRNA. Moreover, we shed light on the miR-34a role in modulating responsiveness to chemotherapy and on the phytonutrients-mediated regulation of miR-34a expression and activity in cancer cells. Given the broad anti-oncogenic activity of miR-34a, we also discuss the substantial benefits of a new therapeutic concept based on nanotechnology delivery of miRNA mimics. In fact, the replacement of oncosuppressor miRNAs provides an effective strategy against tumor heterogeneity and the selective RNA-based delivery systems seems to be an excellent platform for a safe and effective targeting of the tumor. Nature Publishing Group 2014-09 2014-09-23 /pmc/articles/PMC4222652/ /pubmed/25247240 http://dx.doi.org/10.1038/mtna.2014.47 Text en Copyright © 2014 American Society of Gene & Cell Therapy http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Review
Misso, Gabriella
Di Martino, Maria Teresa
De Rosa, Giuseppe
Farooqi, Ammad Ahmad
Lombardi, Angela
Campani, Virginia
Zarone, Mayra Rachele
Gullà, Annamaria
Tagliaferri, Pierosandro
Tassone, Pierfrancesco
Caraglia, Michele
Mir-34: A New Weapon Against Cancer?
title Mir-34: A New Weapon Against Cancer?
title_full Mir-34: A New Weapon Against Cancer?
title_fullStr Mir-34: A New Weapon Against Cancer?
title_full_unstemmed Mir-34: A New Weapon Against Cancer?
title_short Mir-34: A New Weapon Against Cancer?
title_sort mir-34: a new weapon against cancer?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222652/
https://www.ncbi.nlm.nih.gov/pubmed/25247240
http://dx.doi.org/10.1038/mtna.2014.47
work_keys_str_mv AT missogabriella mir34anewweaponagainstcancer
AT dimartinomariateresa mir34anewweaponagainstcancer
AT derosagiuseppe mir34anewweaponagainstcancer
AT farooqiammadahmad mir34anewweaponagainstcancer
AT lombardiangela mir34anewweaponagainstcancer
AT campanivirginia mir34anewweaponagainstcancer
AT zaronemayrarachele mir34anewweaponagainstcancer
AT gullaannamaria mir34anewweaponagainstcancer
AT tagliaferripierosandro mir34anewweaponagainstcancer
AT tassonepierfrancesco mir34anewweaponagainstcancer
AT caragliamichele mir34anewweaponagainstcancer